These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8360182)

  • 1. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS; Pizzo SV
    J Biol Chem; 1993 Sep; 268(25):18924-8. PubMed ID: 8360182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assignment of the binding site for tissue plasminogen activator on human fibronectin.
    Wang L; Lin XH; Cui DF; Wang ZY; Chi CW
    J Biol Chem; 1994 Feb; 269(6):4332-6. PubMed ID: 8308001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    J Biol Chem; 1993 Sep; 268(25):18917-23. PubMed ID: 8360181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM; Conrad HE; Pizzo SV
    Biochemistry; 1991 Nov; 30(45):10999-1003. PubMed ID: 1932024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
    Stack MS; Gray RD; Pizzo SV
    Cancer Res; 1993 May; 53(9):1998-2004. PubMed ID: 8481902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
    Salonen EM; Saksela O; Vartio T; Vaheri A; Nielsen LS; Zeuthen J
    J Biol Chem; 1985 Oct; 260(22):12302-7. PubMed ID: 2413022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin.
    Parkkinen J; Rauvala H
    J Biol Chem; 1991 Sep; 266(25):16730-5. PubMed ID: 1909331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS; Pizzo SV
    Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain.
    Stack S; Gray RD; Pizzo SV
    Biochemistry; 1991 Feb; 30(8):2073-7. PubMed ID: 1847824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
    Kost C; Benner K; Stockmann A; Linder D; Preissner KT
    Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains.
    Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ
    Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional recognition sites in the C-terminal heparin-binding domain of fibronectin promote adhesion of PMA-treated U937 cells.
    Kato K; Hashimoto Y; Kanamori H; Okubo T; Mohri H
    Peptides; 1998; 19(1):7-13. PubMed ID: 9437731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110.
    Praus M; Kettelgerdes G; Baier M; Holzhütter HG; Jungblut PR; Maissen M; Epple G; Schleuning WD; Köttgen E; Aguzzi A; Gessner R
    Thromb Haemost; 2003 May; 89(5):812-9. PubMed ID: 12719777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.